Total Funding
34
70
Total FundingGrant raised
Growth Score 34 in past quarter
-5 pts
Heat Score 70 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
145318
Blue Therapeutics is a drug discovery and development platform company leveraging the awesome power of receptor interactomics
- Stefan Bluemmers: President & CEOPast Role: The Grunenthal Group, SVP Head New Products
- Phil Portoghese: Co-founder
About the Company
Blue Therapeutics was founded in 2015 by Ajay Yekkirala, David Roberson, Michio Painter and academic founder Phil Portoghese. Blue was born out of the desire to take decades of knowledge and technology from academic research and transform that work into therapeutic solutions that can have positive and lasting impacts for patients in the clinic.
Working in New England where the opioid epidemic has struck particularly hard, this meant asking theirselves why better therapeutic options for pain don't exist.
